Table 2 Mean changes in OCT parameters and visual acuity
From: Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
Baseline | 4 weeks after treatment | p value | |
|---|---|---|---|
Subretinal fluid height (μm) | 113.15 ± 18.69 | 94.18 ± 17.53 | 0.08 |
Visual acuity, LogMAR (Snellen equivalent) | 0.18 ± 0.08 (20/30) | 0.15 ± 0.08 (20/28) | 0.16 |
Nasal choroidal thickness (μm) | 410.00 ± 20.36 | 394.89 ± 17.22 | 0.14 |
Subfoveal choroidal thickness (μm) | 452.07 ± 19.70 | 422.20 ± 18.23 | 0.002 |
Temporal choroidal thickness (μm) | 411.07 ± 21.17 | 395.96 ± 15.69 | 0.33 |
Central macular thickness (μm) | 365.23 ± 26.83 | 339.46 ± 27.29 | 0.04 |